HALO logo
halo search icon
Vericel Corporation
Vericel Corporation
VCEL · NAS

Vericel Corporation

US$35.15

Price Arrow-0.25 (-0.706%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapFakey Shakey - Short (Realtime)HALO AllHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Vericel Corporation Overview

VCEL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VCEL

icon

Telephone

1.617.588.5555

icon

Address

64 Sidney Street, Cambridge, MA 02139-4170

Description

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

VCEL Price Chart

Key Stats

Market Cap

US$1.81B

PE

113.70

EV/EBITDA

77.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 28.95 - 45.97

Trade Value (12mth)

US$5,555,965.00

1 week

7.18%

1 month

3%

YTD

-0.59%

1 year

-14.45%

All time high

697.60

Key Fundamentals

EPS 3 yr Growth

-192.60%

EBITDA Margin

8.20%

Operating Cashflow

$52m

Free Cash Flow Return

12.60%

ROIC

4.00%

Interest Coverage

35.90

Quick Ratio

4.70

Other Data

Shares Outstanding (Fully Diluted)

51m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VCEL Announcements

Latest Announcements

DateAnnouncements
19 May 26
07 May 26
07 May 26
07 May 26
07 May 26

VCEL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.070.210.33locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.070.20.32locklocklock
Growth
%locklocklocklock81.141754.7locklocklock
PE
XlocklocklocklockN/A273.9113.7locklocklock
EV/EBITDA
XlocklocklocklockN/A270.677.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Vericel Corporation (VCEL:NAS)?
Halo FAQ
The current share price of Vericel Corporation (VCEL:NAS) is USD$35.15.
What is the 52-week high share price for Vericel Corporation (VCEL:NAS)?
Halo FAQ
The 52-week high share price for Vericel Corporation (VCEL:NAS) is USD$45.97.
What is the 52-week low share price for Vericel Corporation (VCEL:NAS)?
Halo FAQ
The 52-week low share price for Vericel Corporation (VCEL:NAS) is USD$28.95.
What is the dividend yield for Vericel Corporation (VCEL:NAS)?
Halo FAQ
Vericel Corporation (VCEL:NAS) does not pay a dividend.
What was Vericel Corporation (VCEL:NAS) last dividend payment?
Halo FAQ
Vericel Corporation (VCEL:NAS) does not pay a dividend.
What is the franking level for Vericel Corporation (VCEL:NAS)?
Halo FAQ
Vericel Corporation (VCEL:NAS) has a franking level of 0.00%.
In which sector is Vericel Corporation (VCEL:NAS) classified?
Halo FAQ
Vericel Corporation (VCEL:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Vericel Corporation (VCEL:NAS)?
Halo FAQ
The current P/E ratio for Vericel Corporation (VCEL:NAS) is 113.70.

See beyond the curve.

One solution for research, investing and portfolio management.